Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BSP:ONCO3'
s Pretax Margin % Range Over the Past 10 Years
Min: -64.86 Med: 2.64 Max: 5.51
Current: -64.86
BSP:ONCO3's Pretax Margin % is ranked worse than 88.1% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs BSP:ONCO3: -64.86
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Oncoclinicas Do Brasil Servicos Medicos Pretax Margin % Related Terms
Oncoclinicas Do Brasil Servicos Medicos Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oncoclinicas Do Brasil Servicos Medicos Pretax Margin % Chart
Oncoclinicas Do Brasil Servicos Medicos Annual Data
BSP:ONCO3 vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Oncoclinicas Do Brasil Servicos Medicos's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oncoclinicas Do Brasil Servicos Medicos Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oncoclinicas Do Brasil Servicos Medicos's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Oncoclinicas Do Brasil Servicos Medicos's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) has a Pretax Margin % of -37.57% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. According to the industry distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #585 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 88.1%.
Is Oncoclinicas Do Brasil Servicos Medicos' Pretax Margin % too high?
Oncoclinicas Do Brasil Servicos Medicos' current Pretax Margin % is -37.57%. Based on the distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #585 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oncoclinicas Do Brasil Servicos Medicos has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oncoclinicas Do Brasil Servicos Medicos' Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Oncoclinicas Do Brasil Servicos Medicos ranks #585 out of 664 companies for Pretax Margin %. This places Oncoclinicas Do Brasil Servicos Medicos in the lower half of its industry. The industry median Pretax Margin % is 4.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Oncoclinicas Do Brasil Servicos Medicos and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncoclinicas Do Brasil Servicos Medicos's current Pretax Margin % is -37.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncoclinicas Do Brasil Servicos Medicos stock overvalued right now?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) is currently considered Possible Value Trap. The stock's GF Value™ is R$3.47, compared to a current price of R$0.78 — trading 77.5% below its estimated fair value. The current Pretax Margin % is -37.57%. Oncoclinicas Do Brasil Servicos Medicos' overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3), the current Pretax Margin % is -37.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Overvalued in 2026?
Based on GuruFocus' analysis, Oncoclinicas Do Brasil Servicos Medicos stock appears to be undervalued.
The current stock price of R$0.78 is trading 77.5% below its estimated GF Value™ of R$3.47.
GuruFocus considers Oncoclinicas Do Brasil Servicos Medicos to be Possible Value Trap.
Key valuation signals for BSP:ONCO3:
Pretax Margin %: -37.57%
GF Value™: R$3.47 vs. price of R$0.78 (77.5% below fair value)
No single metric tells the full story. See the BSP:ONCO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oncoclinicas Do Brasil Servicos Medicos Business Description
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
46GF Score
Get the complete analysis for BSP:ONCO3
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:ONCO3 has been successfully added to your 
